We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ingenza Collaborates With Johnson Matthey for Efficient Industrial Enzyme Synthesis
Product News

Ingenza Collaborates With Johnson Matthey for Efficient Industrial Enzyme Synthesis

Ingenza Collaborates With Johnson Matthey for Efficient Industrial Enzyme Synthesis
Product News

Ingenza Collaborates With Johnson Matthey for Efficient Industrial Enzyme Synthesis


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Ingenza Collaborates With Johnson Matthey for Efficient Industrial Enzyme Synthesis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Biotechnology company Ingenza is excited to report the successful conclusion to its recent six-month project with Johnson Matthey, a speciality chemicals and sustainable technologies supplier. Together, the companies have developed new, efficient approaches for the production of industrially-relevant enzymes – including cytochrome P450 – through judicious selection of suitable microbial hosts.


Ingenza combined its comprehensive panel of microbial hosts, including Pichia pastoris, Saccharomyces cerevisiae, Escherichia coli and Bacillus subtilis with its visABLE® platform, and a proprietary predictive codon modification algorithm to select favourable genetic elements and significantly increase expression of the candidate enzymes. This approach was combined with automated high throughput screening of thousands of colonies performed at the Edinburgh Genome Foundry, using highly sensitive functional enzyme assays designed by Ingenza to rapidly identify the optimally performing clones with the highest level of enzyme secretion and activity towards different substrates.


Dr Ian Fotheringham, Managing Director at Ingenza, commented: “We have thoroughly enjoyed working closely with the team at Johnson Matthey over the last six months. We truly value this relationship, and the ease of communication between our companies has been critical to the project’s success. We look forward to a continued collaboration with Johnson Matthey, sharing our expertise and knowledge while consistently delivering our services.”


Dr Martin Hayes, Biotechnology Lead at Johnson Matthey, added: “We are very happy with the outcome of our collaboration with Ingenza, which has resulted in the successful expression of two very valuable enzymes. Ingenza was able to promptly deliver cell banks of different microbial strains, along with comprehensive reports, enabling us to conduct our in-house work in a timely manner. The company’s team of experts has shown great capacity to help us on this project, and we look forward to working with Ingenza again in the future.”

  

Advertisement